Search research articles
Contact Us
Filters
Showing results (51-60 of 666) with videos related to
Page
of 67
Sort By:
Biochemistry
|
March 15, 2006
Structure of purine-purine mispairs during misincorporation and extension by Escherichia coli DNA polymerase I
Angie M Kretulskie, Thomas E Spratt
European Urology Oncology
|
May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?
Daniel E Spratt, Felix Y Feng
European Urology
|
June 10, 2022
Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114
Amar U Kishan, Daniel E Spratt
International Journal of Molecular Sciences
|
January 13, 2021
Structural Insights into Ankyrin Repeat-Containing Proteins and Their Influence in Ubiquitylation
Emma I Kane, Donald E Spratt
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2020
Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize Therapy
Daniel E Spratt, Jonathan D Tward
International Journal of Molecular Sciences
|
February 10, 2024
New Discoveries on Protein Recruitment and Regulation during the Early Stages of the DNA Damage Response Pathways
Kelly L Waters, Donald E Spratt
Prostate Cancer and Prostatic Diseases
|
December 16, 2022
Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
Angela Y Jia, Daniel E Spratt
The Lancet. Oncology
|
October 2, 2025
Revisiting prostate cancer active surveillance candidacy
Daniel E Spratt, Edward M Schaeffer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2018
Reply to A.J. Chang et al and A. Gomez-Iturriaga et al
Daniel E Spratt, Peter C Carroll
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?
Jorge A Garcia, Daniel E Spratt
Page
of 67
Search research articles
Search
Showing results (51-60 of 666) with videos related to
Sort By:
Page
of 67
Biochemistry
|
March 15, 2006
Structure of purine-purine mispairs during misincorporation and extension by Escherichia coli DNA polymerase I
Angie M Kretulskie, Thomas E Spratt
European Urology Oncology
|
May 18, 2019
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?
Daniel E Spratt, Felix Y Feng
European Urology
|
June 10, 2022
Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114
Amar U Kishan, Daniel E Spratt
International Journal of Molecular Sciences
|
January 13, 2021
Structural Insights into Ankyrin Repeat-Containing Proteins and Their Influence in Ubiquitylation
Emma I Kane, Donald E Spratt
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2020
Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize Therapy
Daniel E Spratt, Jonathan D Tward
International Journal of Molecular Sciences
|
February 10, 2024
New Discoveries on Protein Recruitment and Regulation during the Early Stages of the DNA Damage Response Pathways
Kelly L Waters, Donald E Spratt
Prostate Cancer and Prostatic Diseases
|
December 16, 2022
Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
Angela Y Jia, Daniel E Spratt
The Lancet. Oncology
|
October 2, 2025
Revisiting prostate cancer active surveillance candidacy
Daniel E Spratt, Edward M Schaeffer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2018
Reply to A.J. Chang et al and A. Gomez-Iturriaga et al
Daniel E Spratt, Peter C Carroll
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?
Jorge A Garcia, Daniel E Spratt
Page
of 67